Compare ACMR & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACMR | LIVN |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.5B |
| IPO Year | 2017 | 2015 |
| Metric | ACMR | LIVN |
|---|---|---|
| Price | $63.76 | $70.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $50.00 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 1.3M | 790.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.24 | ★ 0.40 |
| Revenue | ★ $74,643,000.00 | N/A |
| Revenue This Year | $29.37 | $9.79 |
| Revenue Next Year | $23.16 | $6.63 |
| P/E Ratio | $263.96 | ★ $179.70 |
| Revenue Growth | ★ 104.47 | N/A |
| 52 Week Low | $21.87 | $41.02 |
| 52 Week High | $71.65 | $73.30 |
| Indicator | ACMR | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 59.53 |
| Support Level | $47.48 | $60.76 |
| Resistance Level | $68.63 | $71.58 |
| Average True Range (ATR) | 4.52 | 2.78 |
| MACD | 1.00 | 0.94 |
| Stochastic Oscillator | 80.93 | 83.07 |
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.